腹部实体器官移植受者脓毒症的免疫特征:多中心前瞻性队列研究
该研究为SepsisDataNet.NRW前瞻性多中心队列(n=538)的事后分析,比较腹部实体器官移植(SOT)与非SOT脓毒症患者的临床结局与免疫特征。SOT患者30天生存率84% vs 66%,校正HR 0.49(95%CI 0.26-0.95)。SOT患者IL-6、TNF-α较低而IL-18较高,适应性免疫细胞减少但单核细胞HLA-DR表达较高,蛋白组学富集先天免疫、补体和脂代谢网络,PBMC中GLUT1表达增加及TFAM/TFB2M相互作用增强。非脓毒症肾移植队列(e:KID)配对血清代谢组学显示移植后12个月血糖较高、乳酸较低。结论提示腹部SOT脓毒症患者存在炎症减弱、部分先天免疫保留及免疫代谢标志物改变的独特表型。
要点
- 腹部SOT脓毒症患者30天生存率84%,非SOT患者66%,校正HR 0.49(95%CI 0.26-0.95)。
- SOT患者细胞因子谱改变:IL-6和TNF-α较低,IL-18较高。
- SOT患者适应性免疫细胞减少,但单核细胞HLA-DR表达较高,提示先天免疫功能相对保留。
- SOT患者PBMC中GLUT1表达增加、TFAM/TFB2M相互作用增强,提示独特免疫代谢标志物。
- e:KID队列移植后12个月血清葡萄糖较高、乳酸较低,伴脂质和支链氨基酸谱改变。
适用人群与场景
- 腹部实体器官移植(SOT)后发生脓毒症的患者,来自SepsisDataNet.NRW前瞻性多中心队列(n=538)的事后分析。
- 非脓毒症肾移植队列(e:KID)用于补充探索性分析,以减少临床混杂。
诊断标准与关键阈值
- 脓毒症定义:由感染引起的宿主反应失调导致危及生命的器官功能障碍。
- 原文未提及具体的器官功能障碍评分界值或脓毒症诊断标准名称(如Sepsis-3)。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:前瞻性多中心队列(SepsisDataNet.NRW)的事后分析,样本量n=538。
- 主要结局:SOT患者30天生存率84%,非SOT患者66%,校正HR 0.49(95%CI 0.26-0.95)。
- 细胞因子:SOT患者IL-6和TNF-α较低,IL-18较高。
- 流式细胞术:SOT患者适应性免疫细胞减少,单核细胞HLA-DR表达较高。
- 蛋白组学:SOT患者富集先天免疫、补体和脂代谢反应网络。
- PLA:SOT患者GLUT1表达增加,TFAM/TFB2M相互作用增强。
- e:KID队列:移植后12个月血清葡萄糖较高、乳酸较低,脂质和支链氨基酸谱改变。
证据类型、等级与局限
- 证据类型:前瞻性多中心队列研究的事后分析。
- 局限:事后分析;e:KID为非脓毒症肾移植队列的补充探索性分析;原文未提及盲法或样本量估算。
对床旁实践的改变
- 腹部SOT脓毒症患者可能表现为炎症反应减弱(IL-6、TNF-α较低),但生存率较高,临床不应仅凭炎症指标低而低估病情。
- 单核细胞HLA-DR表达较高提示先天免疫功能相对保留,但原文未提供基于此的干预推荐。
- 原文未提及改变具体治疗(如免疫抑制剂调整、剂量)的建议。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is defined as life-threatening organ dysfunction resulting from a dysregulated host response to infection. Patients with prior abdominal solid organ transplantation (SOT) are highly susceptible to infection due to chronic immunosuppression, yet exhibit improved survival once sepsis occurs. The underlying mechanisms remain poorly understood.
METHODS: We conducted a post hoc analysis within a prospective multicenter cohort of septic patients (SepsisDataNet.NRW; n = 538). Clinical outcomes were assessed using Kaplan-Meier analysis and multivariable Cox regression. Immune profiling included serum cytokines, flow cytometric immunophenotyping, plasma proteomics, and intracellular signaling using proximity ligation assays (PLA) in peripheral blood mononuclear cells (PBMCs). To reduce clinical confounding, complementary exploratory analyses were performed in a non-septic kidney transplant cohort (e:KID).
RESULTS: SOT patients demonstrated improved 30-day survival compared with non-SOT patients (84% vs. 66%; adjusted HR 0.49, 95% CI 0.26-0.95). Cytokine analysis revealed lower IL-6 and TNF-α levels alongside higher IL-18 concentrations, indicating an altered inflammatory profile. Flow cytometry showed reductions in adaptive immune cells but relatively preserved innate immune function, reflected by higher monocytic HLA-DR expression. Proteomics identified enrichment of innate immune, complement, and lipid metabolic response networks. PLA-based cellular analyses revealed increased GLUT1 expression and enhanced TFAM/TFB2M interaction in SOT patients, indicating a distinct immunometabolic marker profile. In e:KID patients paired serum metabolomics demonstrated higher glucose and lower lactate concentrations 12 months after transplantation, accompanied by broader alterations in lipid and branched-chain amino acid profiles.
CONCLUSION: In patients with sepsis, abdominal SOT is associated with significant better survival than in non-SOT patients. Septic abdominal SOT patients display a distinct immune phenotype characterized by attenuated systemic inflammation, relative preservation of selected innate immune readouts, and alterations in immunometabolic markers.
参考来源
- Witowski A, Bracht T, Kröger L, et al. Immunological signatures of sepsis in abdominal solid organ transplant recipients: A multilayer and multicentric prospective cohort study. Intensive Care Med. 2026. PMID: 42955323. doi:10.1007/s00134-026-08612-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。